Ontario funding new treatment for advanced-stage prostate cancer
- Ontario will publicly fund a new treatment for advanced-stage prostate cancer, according to Health Minister Sylvia Jones.
- Pluvicto, approved by Health Canada in August 2022, targets cancer cells using a radioactive drug.
- Ontario is the first Canadian jurisdiction to fund and administer Pluvicto for patients.
- The treatment is expected to be available at most cancer treatment centers in Ontario in the coming months.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left2Leaning Right1Center0Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage